Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T18:32:05.656Z.
Calculation as of: 2026-10-06T18:32:05.656Z.
Quote observation: 2026-10-06T18:29:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: acb65a17080c98cb556e8dedfcd99ff418fc0d96cba63b9d245ba9f7ac680701
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$12.43M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.46M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.56M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.53M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $12.40M | N/A | N/A | N/A | N/A |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.43M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.19M | N/A | 9.96 | 9.96 | 9.96 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.46M | N/A | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.54M | N/A | 4.78 | 4.78 | 4.78 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.56M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.66M | N/A | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.65M | N/A | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.53M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.22M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
